Lyndra Therapeutics on Muck Rack

Lyndra Therapeutics

As seen in: Pittsburgh Post-Gazette, New Atlas, The Lancet, Press-Telegram, Buffalo News, Lethbridge Herald, Financial Content, Bingham News Chronicle, myMotherLode.com, Starkville Daily News and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lyndra

Contact Lyndra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Long-acting oral weekly risperidone (LYN-005) for schizophrenia in the USA (STARLYNG-1): a multicentre, open-label, non-randomised phase 3 trial

|
By Leslie Citrome, Lyndra Therapeutics, Giovanni Traverso, Todd Dumas
| The Lancet
Get full text access Log in, subscribe or purchase for full access. References 1. Jauhar, S ∙ Johnstone, M ∙ McKenna, PJ Schizophrenia Lancet. 2022; 399:473-486 2. Milz, R ∙ Benson, C ∙ Knight, K ∙ et al. The effect of longer dosing intervals for long-acting injectable antipsychotics on outcomes in schizophrenia Neuropsychiatr Dis Treat. 2023; 19:531-545 3.
Open in Who Shared Issue with article?

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

|
By Lyndra Therapeutics
| Financial Content
Lyndra Therapeutics®, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, today announced the Board of Directors has appointed Adam Sayer as President and Chief Executive Officer effective immediately. He will also serve on the company's Board of Directors. Sayer was most recently Chief Transformation Officer at Envision Healthcare, overseeing strategy, transformation and payer negotiations.
Open in Who Shared View Duplicates (56) Issue with article?

Lyndra Therapeutics Announces Adam Sayer Appointed President and CEO

|
By Lyndra Therapeutics
| Value Investing News
Open in Who Shared Issue with article?
See all 133 articles

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Get in touch with Lyndra

Contact Lyndra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified